Similar to other CXCRs, CXCR6–CXCL16 could recruit immune cells (e.g., CD4+ and CD8+ T cells) to cancer sites to affect cancer progression, but the cell-specific functions of CXCR6 remain largely unclear (Xun et al., 2020). This evidence concerns the gene CXCR6 and cancer.